Table 3.
MM/GBSA of the best candidate compounds and protein targets for each target.
| Chemical compound | Target | Van der Waals force (kJ/mol) | Electrostatic potential energy (kJ/mol) | Polar solvation energy (kJ/mol) | Surface solvation (kJ/mol) | Binding free energy (kJ/mol) |
|---|---|---|---|---|---|---|
| Ligand063 | AKT1 | −258.71 ± 16.21 | −89.23 ± 13.49 | 220.17 ± 18.22 | −25.37 ± 1.46 | −178.23 ± 18.29 |
| Ligand121 | IL6 | −229.17 ± 13.98 | −101.37 ± 17.21 | 232.01 ± 16.31 | −30.19 ± 1.01 | −156.91 ± 17.35 |
| Ligand113 | STAT3 | −252.66 ± 18.21 | −92.37 ± 15.76 | 219.32 ± 19.06 | −28.37 ± 0.92 | −176.22 ± 16.47 |
| Ligand103 | TLR4 | −210.37 ± 12.90 | −99.28 ± 16.01 | 211.39 ± 17.88 | −33.51 ± 1.33 | −180.53 ± 19.85 |
| Ligand103 | TNF | −199.58 ± 17.26 | −70.56 ± 12.99 | 245.62 ± 15.90 | −32.02 ± 1.47 | −210.26 ± 22.01 |
| Ligand073 | VEGFA | −241.11 ± 11.08 | −118.34 ± 13.37 | 260.79 ± 15.37 | −27.63 ± 0.89 | −128.83 ± 19.37 |